Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.75 USD | -1.55% | +6.03% | -24.24% |
May. 14 | Transcript : ScPharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | ScPharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 38.98M | Sales 2025 * | 95.73M | Capitalization | 171M |
---|---|---|---|---|---|
Net income 2024 * | -58M | Net income 2025 * | -30M | EV / Sales 2024 * | 4.39 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.79 x |
P/E ratio 2024 * |
-3.23
x | P/E ratio 2025 * |
-6.48
x | Employees | 136 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.28% |
Latest transcript on scPharmaceuticals Inc.
1 day | -1.55% | ||
1 week | +6.03% | ||
Current month | +6.26% | ||
1 month | +5.32% | ||
3 months | -17.25% | ||
6 months | -9.52% | ||
Current year | -24.24% |
Managers | Title | Age | Since |
---|---|---|---|
John Tucker
CEO | Chief Executive Officer | 61 | 16-12-31 |
Rachael Nokes
DFI | Director of Finance/CFO | 49 | 14-08-31 |
John Mohr
CTO | Chief Tech/Sci/R&D Officer | - | 17-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 13-12-31 | |
Klaus Veitinger
BRD | Director/Board Member | 62 | 17-11-20 |
John Tucker
CEO | Chief Executive Officer | 61 | 16-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 4.75 | -1.55% | 237,059 |
24-05-16 | 4.825 | +5.58% | 312,867 |
24-05-15 | 4.57 | +1.56% | 828,706 |
24-05-14 | 4.5 | +3.45% | 347,143 |
24-05-13 | 4.35 | -2.90% | 179,735 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.24% | 171M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- SCPH Stock